Pulsatile secretion of the islet hormones at an interval of 10-14 minutes has now been demonstrated conclusively in several species including man. The proposed work will utilize insights gained from in vitro studies performed in our laboratory in an effort to comprehensively assess the impact of pulsatile insulin secretion in the whole animal. The long term objective is to devise better insulin treatment strategies for human diabetics based on studies of pulsatile insulin administration to nonhuman primates. Work will proceed in three sequential stages each of which addresses a separate specific aim. First, the importance of pulsatile insulin secretion in normal physiology will be assessed by comparing the effects of continuous portal insulin replacement with those of pulsatile portal replacement at the natural secretory interval. Responses studied will include hepatic glucose production, glucose clearance, ketogenesis, lipolysis, glucose counterregulation, and entrainment of glucagon secretion. Second, the consequences of varying the interval at which insulin pulses are administered peripherally will be examined. Previous in vitro work has suggested that differences in the frequency responsiveness of peripheral and hepatic tissues might be exploited to enhance the hepatic effects of peripherally- administered insulin. Finally, the efficacy of long term continuous and pulsatile insulin replacement in streptozotocin diabetic primates will be compared. The frequency of pulsatile insulin administration found in the second phase of this work to optimize hepatic responses will be used in these treatment trials. In future proposals the understanding gained in primates will be implemented with programmable hormone infusion technology to evaluate the efficacy of pulsatile insulin therapy of human diabetics.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK038847-04
Application #
3238394
Study Section
Metabolism Study Section (MET)
Project Start
1987-07-01
Project End
1992-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
4
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Weigle, D S; Hooton, T M; Toivola, B et al. (1996) Frequency of thyroid disease among Southeast Asian primary care patients. J Clin Pharm Ther 21:29-35
Bagdade, J D; Buchanan, W F; Pollare, T et al. (1995) Abnormal lipoprotein phospholipid composition in patients with essential hypertension. Atherosclerosis 117:209-15
Bagdade, J D; Koerker, D J; Ritter, M C et al. (1995) Accelerated cholesteryl ester transfer in baboons with insulin-requiring diabetes mellitus. Horm Metab Res 27:70-5
Wilson, B E; Deeb, S; Florant, G L (1992) Seasonal changes in hormone-sensitive and lipoprotein lipase mRNA concentrations in marmot white adipose tissue. Am J Physiol 262:R177-81
Weigle, D S; Rumbaoa, A V; Goodner, C J (1991) Lack of evidence for improvement in long-term glycemic control by pulsatile insulin infusion in streptozocin-induced diabetic baboon. Diabetes 40:349-57
Weigle, D S; Brunzell, J D (1990) Assessment of energy expenditure in ambulatory reduced-obese subjects by the techniques of weight stabilization and exogenous weight replacement. Int J Obes 14 Suppl 1:69-77;discussion 77-81
Goodner, C J; Koerker, D J; Weigle, D S et al. (1989) Decreased insulin- and glucagon-pulse amplitude accompanying beta-cell deficiency induced by streptozocin in baboons. Diabetes 38:925-31
Weigle, D S; Callahan, D B; Fellows, C L et al. (1989) Preliminary assessment of very low calorie diets by conventional and signal-averaged electrocardiography. Int J Obes 13:691-7